Nafimidone
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141569This classification denotes an anticonvulsant agent with the molecular formula C15H12N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HZU3IQ1EWW, chemically known as 2-imidazol-1-yl-1-naphthalen-2-ylethanone but generally known as nafimidone, which bears US NIH Compound Identifier 51200. European Medicines Agency schedules nafimidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09122MIG. The term NAFIMIDONE is an International Non-Proprietary Name or INN. Most nations schedule nafimidone under HS 29332990 and SITC 51573. As of Q4 2014, NAFIMIDONE remains the US FDA Preferred Term for this commodity. SMILES: C1=CC=C2C=C(C=CC2=C1)C(=O)CN3C=CN=C3.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.